Cargando…

Drug‐Induced Liver Injury by Checkpoint Inhibitors: Benefit of a Causality Assessment Tool

Detalles Bibliográficos
Autores principales:	Weber, Sabine, Benesic, Andreas, Ishigami, Masatoshi, Gerbes, Alexander L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527692/ https://www.ncbi.nlm.nih.gov/pubmed/33024923 http://dx.doi.org/10.1002/hep4.1565

Ejemplares similares

Liver Injury Associated with Metamizole Exposure: Features of an Underestimated Adverse Event
por: Weber, Sabine, et al.
Publicado: (2021)

Drug-induced liver injury: recent advances in diagnosis and risk assessment
por: Kullak-Ublick, Gerd A, et al.
Publicado: (2017)

Proteomics Analysis of Monocyte-Derived Hepatocyte-Like Cells Identifies Integrin Beta 3 as a Specific Biomarker for Drug-Induced Liver Injury by Diclofenac
por: Dragoi, Diana, et al.
Publicado: (2018)

Challenges and Future of Drug-Induced Liver Injury Research—Laboratory Tests
por: Weber, Sabine, et al.
Publicado: (2022)

Update on herbal and dietary supplement-induced liver injury: current gaps and future directions
por: Weber, Sabine, et al.
Publicado: (2023)

Acute liver injury in a patient with adult-onset Still’s disease—the challenge of differential diagnosis
por: Weber, Sabine, et al.
Publicado: (2020)

Letter to the Editor: Homeopathic drug-induced liver injury—an example of biases pertaining to Roussel Uclaf causality assessment method
por: Krishnan P., Arun, et al.
Publicado: (2023)

Hepatic Impairment as a Risk Factor for Drug Safety: Suitability and Comparison of Four Liver Scores as Screening Tools
por: Golla, Kathrin, et al.
Publicado: (2023)

How to use immune checkpoint inhibitor in ovarian cancer?
por: Park, Junsik, et al.
Publicado: (2019)

Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica
por: van der Geest, Kornelis S M, et al.
Publicado: (2022)

Adjuvant and neoadjuvant use of immune checkpoint inhibitors in NSCLC
por: Walia, Anushka, et al.
Publicado: (2023)

Causality fields in nonlinear causal effect analysis
por: Wang, Aiguo, et al.
Publicado: (2022)

Comment on ‘Toxicities associated with immune checkpoint inhibitors: A systematic study’
por: Hosseini, Mohammad-Salar, et al.
Publicado: (2023)

Gastrointestinal toxicities associated with immune checkpoint inhibitors: a disproportionality analysis leveraging VigiBase, the WHO Adverse Drug Reaction Database
por: HUANG, Sifu, et al.
Publicado: (2021)

Micronodular Pattern of Organizing Pneumonia or Hypersensitivity Pneumonia Induced by an Immune Checkpoint Inhibitor?
por: Takimoto, Takayuki
Publicado: (2020)

Immune checkpoint inhibitors-associated cardiotoxicity in immunotherapy trials on gastrointestinal cancer patients
por: Li, Yiqun, et al.
Publicado: (2022)

Alopecia areata as an immune-related adverse event associated with response to immune checkpoint inhibitors
por: Suzuki, Rika, et al.
Publicado: (2023)

Reply to Takimoto: Micronodular Pattern of Organizing Pneumonia or Hypersensitivity Pneumonia Induced by an Immune Checkpoint Inhibitor?
por: Yamasaki, Masahiro, et al.
Publicado: (2020)

Immune-related Adverse Events in Patients With Cancer Receiving Influenza Vaccination and Immune Checkpoint Inhibitors
por: Groeneveld, Geert H, et al.
Publicado: (2020)

MED12 mutation as a potential predictive biomarker for immune checkpoint inhibitors in pan-cancer
por: Zhou, Yong, et al.
Publicado: (2022)

Cardiotoxicity Associated with Immune Checkpoint Inhibitors
por: Minegishi, Shintaro, et al.
Publicado: (2023)

Mechanisms of immune checkpoint inhibitor-mediated liver injury
por: Shojaie, Layla, et al.
Publicado: (2021)

Considerations about causality in observational studies
por: Venturin, Bruna
Publicado: (2021)

Clinical benefit of immune checkpoint inhibitors approved by US Food and Drug Administration
por: Liang, Fei, et al.
Publicado: (2020)

MDM2/4 amplification predicts poor response to immune checkpoint inhibitors: a pan-cancer analysis
por: Fang, Wenfeng, et al.
Publicado: (2020)

A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT)
por: Tillmann, Hans L., et al.
Publicado: (2022)

How Compatible Are Immune Checkpoint Inhibitors and Thermal Ablation for Liver Metastases?
por: Minami, Yasunori, et al.
Publicado: (2022)

A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI Registry
por: Björnsson, Einar S., et al.
Publicado: (2022)

Decolonising medical causality in the COVID-19 pandemic
por: Visser, Adele
Publicado: (2022)

Epidermodysplasia Verruciformis and Breast Cancer - Casual or Causal?
por: Montero-Vilchez, Trinidad, et al.
Publicado: (2022)

Immune-related genetic prognostic index to predict prognosis and immune checkpoint inhibitor therapy efficiency in acute myeloid leukemia
por: Cao, Xunhong, et al.
Publicado: (2023)

Encephalitis in a patient with hypopharynx cancer treated with immune checkpoint inhibitors and radiotherapy: a case report and review of the literature
por: Kang, Yan, et al.
Publicado: (2023)

Whether early-stage (N0 neck) oral cancer patients received primary tumor resection without neck dissection benefit from immune checkpoint therapy
por: Liu, Wei, et al.
Publicado: (2023)

Erector spinae plane block: inexplicable benefits in acute gastrointestinal injury. Author's reply
por: Cai, Jing, et al.
Publicado: (2023)

Comments on ‘Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer’
por: Takada, K., et al.
Publicado: (2022)

On the interpretability and computational reliability of frequency-domain Granger causality
por: Faes, Luca, et al.
Publicado: (2017)

Zinc and Coronavirus Disease 2019: Causal or Casual Association?
por: Khurana, Alkesh Kumar, et al.
Publicado: (2021)

The association of talc use and ovarian cancer: biased or causal
por: Cramer, Daniel W.
Publicado: (2021)

Authors’ reply for “Considerations about causality in observational studies”
por: Wen, Bo, et al.
Publicado: (2021)

Liver function test abnormalities at hospital admission are associated with severe course of SARS-CoV-2 infection: a prospective cohort study
por: Weber, Sabine, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_crtd8kgtsp2qjgjvll0kumdikd